Chinese regulators revise medtech advertising rules
This article was originally published in Clinica
Executive Summary
The Chinese State Food and Drug Administration (SFDA) has revised its rules on the advertising of medical devices. Here, Evangeline Loh, vice-president of regulatory affairs at the international consultancy, Emergo Group, tells Clinica readers how to apply for permission to advertise a product, what to include in the applications and the timelines for expecting an approval.
You may also be interested in...
Medical Device Registration in Mexico
Evangeline Loh describes the regulatory process for marketing medical devices in Mexico and highlights some new rules affecting importers.